RBFC
ALXN

Roman Butler Fullerton & Co’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Roman Butler Fullerton & Co’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,450
Closed -$331K – 182
2019
Q1 		$331K Buy
+2,450
New +$331K 0.23% 135